Linking pages
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet https://www.thelancet.com/journals/lancet/article/piis0140-6736(20)31604-4/fulltext 2846 comments
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis | The BMJ https://www.bmj.com/content/371/bmj.m4750 1198 comments
- The EMA covid-19 data leak, and what it tells us about mRNA instability | The BMJ https://www.bmj.com/content/372/bmj.n627 214 comments
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2102214 174 comments
- COVID-19 vaccine in Russia: 'It's less of a vaccine and more of a Molotov cocktail', expert says | Euronews https://www.euronews.com/2020/08/11/covid-19-vaccine-in-russia-it-s-less-of-a-vaccine-and-more-of-a-molotov-cocktail-expert-sa 144 comments
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext 144 comments
- US coronavirus: Dr. Anthony Fauci says we can put an end to the pandemic if vaccine widely accepted | CNN https://edition.cnn.com/2020/07/27/health/us-coronavirus-monday/index.html?amp%3Butm_content=2020-07-27t00husariamarketinglondon&%3Butm_medium=social&%3Butm_source=husariakingston 91 comments
- China joins global vaccine alliance, filling “leadership vacuum” left by Trump | Ars Technica https://arstechnica.com/science/2020/10/china-joins-global-vaccine-alliance-filling-leadership-vacuum-left-by-trump/ 86 comments
- La Russia vuole avviare una vaccinazione di massa entro ottobre - Il Post https://www.ilpost.it/2020/08/03/russia-vaccino-coronavirus-ottobre/ 69 comments
- What good is a vaccine if Americans won't roll up their sleeves? (opinion) | CNN https://www.cnn.com/2020/08/01/opinions/vaccine-fears-public-health-messaging-yasmin/index.html 65 comments
- Nose Spray Vaccines Could Quash COVID Virus Variants - Scientific American https://www.scientificamerican.com/article/nose-spray-vaccines-could-quash-covid-virus-variants/ 34 comments
- Fear mounts Trump may pressure FDA to rush Covid-19 vaccine by election | Donald Trump | The Guardian https://www.theguardian.com/us-news/2020/jun/22/trump-circle-pressure-fda-rush-covid-19-vaccine-election 34 comments
- Russia Sets Mass Vaccination for October After Shortened Trial - The New York Times https://www.nytimes.com/2020/08/02/world/europe/russia-trials-vaccine-october.html 29 comments
- Vaccine nationalism threatens global efforts race to stop coronavirus https://www.usatoday.com/story/news/health/2020/07/12/vaccine-nationalism-threatens-global-efforts-race-stop-coronavirus/5384850002/ 28 comments
- Bill Gates says COVID-19 drugs should go where needed, not just ‘the highest bidder’ - The Verge https://www.theverge.com/2020/7/11/21320969/microsoft-bill-gates-vaccine-coronavirus-covid 26 comments
- Untested COVID-19 vaccine, Sputnik V, begins 40,000-person trial next week | Ars Technica https://arstechnica.com/science/2020/08/untested-covid-19-vaccine-sputnik-v-begins-40000-person-trial-next-week/ 25 comments
- Coronavirus: China has been giving potential vaccine to key workers since July | Coronavirus | The Guardian https://www.theguardian.com/world/2020/aug/24/china-has-been-giving-potential-coronavirus-vaccine-to-key-workers-since-july 24 comments
- Moderna coronavirus vaccine: First Phase 3 clinical trial in the United States begins | CNN https://www.cnn.com/2020/07/27/health/coronavirus-vaccine-trial-begins-moderna-phase-3/index.html 20 comments
- CanSino Biologics: World's first inhaled Covid vaccine approved in China for emergency use | CNN https://edition.cnn.com/2022/09/06/china/china-covid-19-vaccine-cansino-intl-hnk/index.html 18 comments
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia - The Lancet https://www.thelancet.com/journals/lancet/article/piis0140-6736(20)31866-3/fulltext 15 comments
Linked pages
Related searches:
Search whole site: site:who.int
Search title: COVID-19 vaccine tracker and landscape
See how to search.